September 22, 2021 Chemicals, Reagents & Kits Licensing, IP, and Legal

Zymo Research Receives CE IVD Mark for Its EZ DNA Methylation-Lightning Kit

PROVEN BISULFITE TECHNOLOGY IDEAL FOR CLINICAL APPLICATIONS IRVINE, Calif., (September 22, 2021) — Today Zymo Research announced its EZ DNA Methylation-Lightning Kit has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and... Read more

November 23, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Receives CE IVD Mark for Its Quick-DNA/RNA Viral MagBead Kit

RELIABLE AND SENSITIVE VIRAL PURIFICATION USED FOR SARS-COV-2 VIRAL DETECTION AND ANALYSIS Zymo Research’s Quick-DNA/RNA Viral MagBead Kit has been cleared for in vitro diagnostic applications for use by EU member states. IRVINE, Calif., (Nov. 23, 2020) — Zymo Research announced today that its Quick-DNA/RNA Viral MagBead Kit was cleared for distribution to the European Union (EU) common market.... Read more

November 10, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Obtains CE IVD Mark for Its Quick SARS-CoV-2 Multiplex Kit

LOW COST, HIGH-SENSITIVITY DIAGNOSTIC TEST FOR COVID-19 DETECTION Zymo Research was recently granted the CE IVD certification for its Quick SARS-CoV-2 Multiplex Kit. IRVINE, Calif., (Nov. 10, 2020) — Zymo Research announced today that it obtained a CE IVD mark for the Quick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of... Read more

September 25, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Granted CE IVD Mark for Sample Collection Devices

SAFE AND RELIABLE SAMPLE PRESERVATION AT AMBIENT TEMPERATURE FOR IVD APPLICATIONS Zymo Research was granted the CE IVD mark for its DNA/RNA Shield™ reagent and collection devices. IRVINE, Calif., (Sept. 25, 2020) — Zymo Research announced that three of its DNA/RNA Shield™ collection devices: 1) DNA/RNA Shield™ collection tube w/ swab, 2) DNA/RNA Shield™ Saliva/Sputum Collection Kit, and 3) DNA/RNA Shield™ Fecal Collection... Read more

August 19, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Granted CE IVD Mark for Quick SARS-CoV-2 rRT-PCR Kit

IRVINE, Calif., (Aug. 19, 2020) — Zymo Research announced that it was recently granted the CE IVD Mark for its Quick SARS-CoV-2 rRT-PCR Kit. To obtain this certification the product had to comply with the Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. The Quick SARS-CoV-2 rRT-PCR Kit is... Read more

July 28, 2020 Clinical Research/Diagn. Informatics & Software Product Launch

Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting

CALIFORNIA LABORATORIES CAN NOW INSTANTLY TRANSMIT COVID-19 DATA TO THE CALREDIE SYSTEM IRVINE, Calif., (July 28, 2020) — Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange (CalREDIE). According to the California Department of Public Health (CDPH) website,... Read more

June 11, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Zymo Research Collaborates With Companies to Support COVID-19 Testing

CALIFORNIA COMPANIES WORK TOGETHER TO MAKE NEW EUA COVID-19 TESTS AVAILABLE IRVINE, Calif., (June 11, 2020) — With the support of Zymo Research products, two California-based companies, Fulgent Genetics located in Temple City and Curative Inc. based in Menlo Park, have received Emergency Use Authorizations from the US Food and Drug Administration for their rRT-PCR tests... Read more

May 12, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Zymo Research Obtains Emergency Use Authorization from FDA for Their Quick SARS-CoV-2 rRT-PCR Kit

Qualitative Test for the Detection of Nucleic Acid From SARS-CoV-2 IRVINE, Calif., (May 12, 2020) — Zymo Research announced today that the US Food and Drug Administration (FDA) has approved its Quick SARS-CoV-2 rRT-PCR Kit (R3011) for Emergency Use Authorization (EUA) for the detection of SARS-CoV-2, the virus that causes COVID-19. The kit is a qualitative test for the... Read more

April 22, 2020 Clinical Research/Diagn. M&A, Partnerships

Opentrons Partners With Zymo Research to Offer an Affordable, Automated COVID-19 Testing Platform

(BROOKLYN, NY – April 22, 2020) – Zymo Research Corp, a California-based life science reagent company and Opentrons Labworks, Inc, makers of affordable and easy-to-use lab robotics, have partnered to create a robust engine for SARS-CoV-2 molecular testing. As the COVID-19 crisis persists, the need for high-throughput, fast turn-around, and affordable testing platforms will become... Read more

February 3, 2020 Life Science Tools Liq. Handling & Robotics Product Launch

Discover the DreamPrep NAP Featuring Zymo Research Workstation and Jump Start Your Nucleic Acid Processing

IRVINE, Calif., (Feb. 3, 2020) — Tecan’s new DreamPrep NAP workstation is designed to simplify your nucleic acid extraction workflows. Tecan has collaborated closely with Zymo Research to offer a ready-to-go processing solution for the ZymoBIOMICS™ 96 MagBead DNA Kit, including walkaway quantification and normalization with an on-board Infinite® 200 PRO reader. The DreamPrep NAP featuring... Read more